Halifax-Backed Envision Pharma Expands Into Asia-Pacific Via ProScribe Acquisition
WASHINGTON & HORSHAM, United Kingdom--(BUSINESS WIRE)--Envision Pharma Group, a global technology and scientific communication company, announced today that it has acquired Queensland, Australia-based ProScribe, a medical writing company. The acquisition will be Envision’s first in the Asia-Pacific region. Terms of the transaction were not disclosed. The Halifax Group (“Halifax”), a leading private equity firm, initially partnered with Envision Pharma and its management team in June 2013.
Help employers find you! Check out all the jobs and post your resume.